Kentaro Tokumo
Hiroshima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Phase II basket study of brigatinib for ALK fusion-positive solid tumors: WJOG15221M/ALLBREAK (a decentralized clinical trial design).
Journal: Future oncology (London, England)
Published: April 15, 2026
Primary Unknown Squamous Cell Carcinoma with the Anaplastic Lymphoma Kinase Fusion Gene That Was Effectively Treated with Alectinib: A Case Report.
Journal: Case reports in oncology
Published: February 18, 2026
Erratum for "Association Between Introduction of the 23-valent Pneumococcal Polysaccharide Vaccine (PPSV23) and Pneumonia Incidence and Mortality Among General Older Population in Japan: A Community-based Study" [J Epidemiol 35(5) (2025) 237-244].
Journal: Journal of epidemiology
Published: September 07, 2025
Comprehensive Genomic Profiling Testing for Castration-Resistant Prostate Cancer in Advanced Elderly Patients: A Single-Center Retrospective Cohort Study.
Journal: The Prostate
Published: April 08, 2025
Diagnostic performance of narrow-band imaging bronchoscopy in assessing tracheobronchial cell morphological abnormalities.
Journal: Annals of thoracic medicine
Published: December 09, 2024
Association Between Introduction of the 23-valent Pneumococcal Polysaccharide Vaccine (PPSV23) and Pneumonia Incidence and Mortality Among General Older Population in Japan: A Community-based Study.
Journal: Journal of epidemiology
Published: December 08, 2024
Successful outcome achieved with adjuvant chemotherapy with irinotecan plus cisplatin in rectal neuroendocrine carcinoma: a case report.
Journal: Surgical case reports
Published: July 24, 2024
Comprehensive genomic profiling testing in Japanese castration-resistant prostate cancer patients: results of a single-center retrospective cohort study.
Journal: Japanese journal of clinical oncology
Published: August 04, 2023
Concurrent Mutations in STK11 and KEAP1 Cause Treatment Resistance in KRAS Wild-type Non-small-cell Lung Cancer.
Journal: Internal medicine (Tokyo, Japan)
Published: March 01, 2023
Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial-Mesenchymal Transition.
Journal: Cancers
Published: November 22, 2022
Conversion from Positive to Negative EGFR Mutation due to Clonal Selection during Long-Term Treatment with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors: A Case Report.
Journal: Case reports in oncology
Published: June 11, 2021
An Autopsy Case of IGF‒Ⅱ Secreting Gastric Cancer with Non‒Islet Cell Tumor Hypoglycemia
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: May 12, 2021
Last Updated: 09/26/2026